These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294 [TBL] [Abstract][Full Text] [Related]
15. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy. Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359 [TBL] [Abstract][Full Text] [Related]
17. Echocardiographic and clinical findings in patients with Fabry disease during long-term enzyme replacement therapy: a nationwide Danish cohort study. Madsen CV; Bundgaard H; Rasmussen ÅK; Sørensen SS; Petersen JH; Køber L; Feldt-Rasmussen U; Petri H Scand Cardiovasc J; 2017 Aug; 51(4):207-216. PubMed ID: 28545342 [TBL] [Abstract][Full Text] [Related]
18. Athletes with implantable cardioverter defibrillators: can they return to competitive sports? Prutkin JM; Ackerman MJ; Drezner JA Heart; 2016 Jan; 102(2):93-4. PubMed ID: 26729607 [No Abstract] [Full Text] [Related]
19. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy]. Hentati M; Ben Ameur I; Kechida Z; Charfeddine H; Hached L; Grati Z; Kammoun S Tunis Med; 2003; 81 Suppl 8():675-9. PubMed ID: 14608758 [TBL] [Abstract][Full Text] [Related]
20. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment. Weidemann F; Niemann M; Breunig F; Herrmann S; Beer M; Störk S; Voelker W; Ertl G; Wanner C; Strotmann J Circulation; 2009 Feb; 119(4):524-9. PubMed ID: 19153271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]